Zhenglin Yi

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Erratum to "Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer".

Erratum to "Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer".

Journal: Biomaterials research

Published: November 17, 2025

Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.

Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48.

Journal: Journal for immunotherapy of cancer

Published: July 16, 2025

TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance.

TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance.

Journal: Theranostics

Published: September 03, 2024

Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling.

Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signaling.

Journal: Cellular & molecular biology letters

Published: March 15, 2024

Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer.

Nanotherapeutic System with Effective Microwave Sensitization and Pyroptosis Programming Enable Synergistic Microwave-Immunotherapy in Bladder Cancer.

Journal: Biomaterials research

Published: December 24, 2023

METTL3 aggravates renal fibrogenesis in obstructive nephropathy via the miR-199a-3p/PAR4 axis.

METTL3 aggravates renal fibrogenesis in obstructive nephropathy via the miR-199a-3p/PAR4 axis.

Journal: European journal of pharmacology

Published: December 21, 2023

CTH-Net: A CNN and Transformer hybrid network for skin lesion segmentation.

CTH-Net: A CNN and Transformer hybrid network for skin lesion segmentation.

Journal: iScience

Published: November 22, 2023

Androgen deprivation therapy, neoadjuvant androgen deprivation therapy, and adjuvant androgen deprivation therapy in patients with locally advanced prostate cancer: a multi-center real-world retrospective study.

Androgen deprivation therapy, neoadjuvant androgen deprivation therapy, and adjuvant androgen deprivation therapy in patients with locally advanced prostate cancer: a multi-center real-world retrospective study.

Journal: World journal of urology

Published: May 17, 2023

HI-MViT: A lightweight model for explainable skin disease classification based on modified MobileViT.

HI-MViT: A lightweight model for explainable skin disease classification based on modified MobileViT.

Journal: Digital health

Published: May 08, 2023

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy.

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy.

Journal: Cancers

Published: September 13, 2022

Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology.

Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology.

Journal: Frontiers in public health

Published: September 05, 2022

Computer-aided diagnosis of prostate cancer based on deep neural networks from multi-parametric magnetic resonance imaging.

Computer-aided diagnosis of prostate cancer based on deep neural networks from multi-parametric magnetic resonance imaging.

Journal: Frontiers in physiology

Published: April 12, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026